$709,000 left.......tick tock. Cant do a lot of production with...

$709,000 left.......tick tock. Cant do a lot of production with that. Maybe the manufacturing companies are giving them an extra long credit time, or goodwill, or a bunch of IOU's
The overall take is that they still, after all these years of bullshit, cant decide how to even present Colostat to the market. There is no path forward other than to suggest it might work better as a triage for Colonoscopies. But isnt that obvious? They didnt need a new CEO to tell the board something you would have naturally thought was a bi-product of using the test for screening. And if a faecal test did come back positive but then they used Colostat ONLY to determine whether to do a Colonoscopy, i would think it would need to have CRC detection rates almost equal of the actual procedure, because if they miss even one bowel cancer no one will ever trust it again.